Scotland's past investment in electronic health records (EHRs) and translational medicine research, coupled with a vibrant healthcare technology industry, positions Scotland as the location to drive forward the stratified medicine agenda globally. The aim of SMS-IC is to prove the principle of stratified clinical trials and in 2013 it will begin a series of exemplar projects which link patient phenotype, genotypic and other data types enabling precision targeting of populations for clinical trials. Although the Ion Proton ™ platform is currently for Research Use Only, the ultimate aim is to take stratified clinical trial models from concept to clinical practice. SMS-IC will run a competition to identify suitable projects and applications are invited from interested parties.A semiconductor chip is at the heart of the Ion Proton's technology. Instead of relying on light-based technology and cameras to capture images of DNA sequences, the Ion Proton ™ System translates chemical information into digital data. The chip enables sequencing to be performed on a massively parallel format, drastically accelerating the sequencing process.
Life Technologies' Ion Proton™ To Power Stratified Medicine Scotland Innovation Centre
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
More than 30 investing pros with skin in the game give you actionable insight and investment ideas.